Notal Vision's artificial-intelligence-aided macular degeneration diagnostic device, called Notal Home OCT, has received breakthrough device designation from the FDA. The home-based optical coherence tomography system is intended for automatic identification of intra- and subretinal fluid in the central 10 degrees of eyes with exudative age-related macular degeneration.
Notal Vision's home-based OCT system gets breakthrough status
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.